Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

被引:784
作者
Du, Heng [2 ,3 ]
Guo, Lan [2 ,3 ]
Fang, Fang [2 ,3 ]
Chen, Doris [2 ,3 ]
Sosunov, Alexander A.
McKhann, Guy M.
Yan, Yilin [1 ]
Wang, Chunyu [1 ]
Zhang, Hong [4 ,5 ]
Molkentin, Jeffery D. [6 ]
Gunn-Moore, Frank J. [7 ]
Vonsattel, Jean Paul [4 ]
Arancio, Ottavio [4 ,5 ]
Chen, John Xi [8 ]
Du Yan, Shi [2 ,3 ,4 ,5 ]
机构
[1] Rensselaer Polytech Inst, Dept Biol, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA
[2] Columbia Univ Coll Phys & Surg, Dept Surg, New York, NY 10032 USA
[3] Columbia Univ Coll Phys & Surg, Dept Neurosurg, New York, NY 10032 USA
[4] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA
[5] Columbia Univ Coll Phys & Surg, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY 10032 USA
[6] Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA
[7] Univ St Andrews, Sch Biol, St Andrews KY16 9TS, Fife, Scotland
[8] Cornell Univ, Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10065 USA
关键词
D O I
10.1038/nm.1868
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclophilin D (CypD, encoded by Ppif) is an integral part of the mitochondrial permeability transition pore, whose opening leads to cell death. Here we show that interaction of CypD with mitochondrial amyloid-beta protein (A beta) potentiates mitochondrial, neuronal and synaptic stress. The CypD-deficient cortical mitochondria are resistant to A beta- and Ca2+-induced mitochondrial swelling and permeability transition. Additionally, they have an increased calcium buffering capacity and generate fewer mitochondrial reactive oxygen species. Furthermore, the absence of CypD protects neurons from A beta- and oxidative stress-induced cell death. Notably, CypD deficiency substantially improves learning and memory and synaptic function in an Alzheimer's disease mouse model and alleviates A beta-mediated reduction of long-term potentiation. Thus, the CypD-mediated mitochondrial permeability transition pore is directly linked to the cellular and synaptic perturbations observed in the pathogenesis of Alzheimer's disease. Blockade of CypD may be a therapeutic strategy in Alzheimer's disease.
引用
收藏
页码:1097 / 1105
页数:9
相关论文
共 56 条
[21]   Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice [J].
Esposito, Luke ;
Raber, Jacob ;
Kekonius, Lisa ;
Yan, Fengrong ;
Yu, Giu-Qiu ;
Bien-Ly, Nga ;
Puolivali, Jukka ;
Scearce-Levie, Kimberly ;
Masliah, Eliezer ;
Mucke, Lennart .
JOURNAL OF NEUROSCIENCE, 2006, 26 (19) :5167-5179
[22]  
Fernández-Vizarra P, 2004, HISTOL HISTOPATHOL, V19, P823, DOI 10.14670/HH-19.823
[23]   Differences in the activation of the mitochondrial permeability transition among brain regions in the rat correlate with selective vulnerability [J].
Friberg, H ;
Connern, C ;
Halestrap, AP ;
Wieloch, T .
JOURNAL OF NEUROCHEMISTRY, 1999, 72 (06) :2488-2497
[24]   Biochemistry - A pore way to die [J].
Halestrap, A .
NATURE, 2005, 434 (7033) :578-579
[25]   Calcium, mitochondria and reperfusion injury: a pore way to die [J].
Halestrap, AP .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2006, 34 :232-237
[26]   Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase [J].
Halestrap, AP ;
Woodfield, KY ;
Connern, CP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (06) :3346-3354
[27]   The permeability transition pore complex: another view [J].
Halestrap, AP ;
McStay, GP ;
Clarke, SJ .
BIOCHIMIE, 2002, 84 (2-3) :153-166
[28]   A MODEL FOR BETA-AMYLOID AGGREGATION AND NEUROTOXICITY BASED ON FREE-RADICAL GENERATION BY THE PEPTIDE - RELEVANCE TO ALZHEIMER-DISEASE [J].
HENSLEY, K ;
CARNEY, JM ;
MATTSON, MP ;
AKSENOVA, M ;
HARRIS, M ;
WU, JF ;
FLOYD, RA ;
BUTTERFIELD, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3270-3274
[29]   Mitochondrial abnormalities in Alzheimer's disease [J].
Hirai, K ;
Aliev, G ;
Nunomura, A ;
Fujioka, H ;
Russell, RL ;
Atwood, CS ;
Johnson, AB ;
Kress, Y ;
Vinters, HV ;
Tabaton, M ;
Shimohama, S ;
Cash, AD ;
Siedlak, SL ;
Harris, PLR ;
Jones, PK ;
Petersen, RB ;
Perry, G ;
Smith, MA .
JOURNAL OF NEUROSCIENCE, 2001, 21 (09) :3017-3023
[30]  
Hou FF, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351296